Page last updated: 2024-11-03

ro 31-8220 and Kidney Neoplasms

ro 31-8220 has been researched along with Kidney Neoplasms in 2 studies

Ro 31-8220: a protein kinase C inhibitor

Kidney Neoplasms: Tumors or cancers of the KIDNEY.

Research Excerpts

ExcerptRelevanceReference
"Four renal cell carcinoma (RCC) cell lines were used."1.32Inhibition of MKP-1 expression potentiates JNK related apoptosis in renal cancer cells. ( Marumo, K; Mizuno, R; Murai, M; Okada, Y; Oya, M; Shiomi, T, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mizuno, R1
Oya, M1
Shiomi, T1
Marumo, K1
Okada, Y1
Murai, M1
Brenner, W1
Benzing, F1
Gudejko-Thiel, J1
Fischer, R1
Färber, G1
Hengstler, JG1
Seliger, B1
Thüroff, JW1

Other Studies

2 other studies available for ro 31-8220 and Kidney Neoplasms

ArticleYear
Inhibition of MKP-1 expression potentiates JNK related apoptosis in renal cancer cells.
    The Journal of urology, 2004, Volume: 172, Issue:2

    Topics: Anisomycin; Apoptosis; Carcinoma, Renal Cell; Cell Cycle Proteins; Dual Specificity Phosphatase 1; H

2004
Regulation of beta1 integrin expression by PKCepsilon in renal cancer cells.
    International journal of oncology, 2004, Volume: 25, Issue:4

    Topics: Carcinoma, Renal Cell; CD18 Antigens; Cell Division; Cell Line, Tumor; Cell Movement; Gene Expressio

2004